Management of Throat Tightness in MCAS Patients

Immediate Actions and Emergency Preparedness

The American Academy of Allergy, Asthma, and Immunology recommends discontinue quercetin completely in MCAS patients with throat tightness, as it represents potential laryngeal angioedema or early anaphylaxis, requiring immediate medical attention 1, 2
Ensure the patient has an epinephrine autoinjector and knows to use it for throat tightness, as laryngeal angioedema requires intramuscular epinephrine 2
Instruct the patient to assume a supine position if hypotension develops and call emergency services 2
If epinephrine is administered, the patient must go to the emergency department by ambulance while remaining supine 2

The American College of Allergy, Asthma, and Immunology recommends H1 receptor antagonists (cetirizine, fexofenadine) at 2-4 times standard doses as first-line therapy for MCAS patients 4
Add H2 receptor antagonists (famotidine) to H1 blockers for enhanced symptom control, as combination therapy provides better histamine blockade 4
Oral cromolyn sodium is particularly effective and prevents mast cell degranulation when combined with antihistamines 4
Leukotriene receptor antagonists (montelukast) should be added if symptoms persist despite antihistamine therapy, particularly if urinary LTE4 levels are elevated 1, 5, 4
Ketotifen, a sedating H1 antihistamine with mast cell-stabilizing properties, can be effective for symptoms that don't respond to non-sedating antihistamines 4

Measure serum tryptase at baseline and during symptomatic episodes (within 30-120 minutes of symptom onset), with an increase of 20% above baseline plus 2 ng/mL considered significant for mast cell activation 6, 4
Treatment should be adjusted based on specific mediator elevations: if histamine products are elevated, focus on antihistamines; if urinary LTE4 levels are increased, use leukotriene antagonists; if prostaglandin metabolites are elevated, consider aspirin (introduced cautiously) 1, 5, 4

The American Gastroenterological Association recommends low-histamine diets may be considered for improving GI and systemic symptoms in MCAS patients, but should be implemented with appropriate nutritional counseling to avoid restrictive eating patterns 3